NCT02935907View on ClinicalTrials.gov

APG-115 in Patients With Advanced Solid Tumors or Lymphomas

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

June 28, 2019

Study Completion Date

June 28, 2019

Conditions
Patients With Advanced Solid Tumor or Lymphoma
Interventions
DRUG

APG-115

Multiple dose cohorts, PO, every other day of a 28 day cycle

Trial Locations (2)

49546

START Midwest, Grand Rapids

78229

The START Center for Cancer Care, San Antonio

Sponsors
All Listed Sponsors
lead

Ascentage Pharma Group Inc.

INDUSTRY